De-risking recruitment & retention across global clinical studies.

Protocol-aligned digital acquisition, ethical pre-screening architectures, and participant retention systems engineered to prevent trial delays, eliminate screen failures, and satisfy stringent IRB/IEC regulatory scrutiny.